[Splenic infarction after warfarin discontinuation during atrial fibrillation]

M Trappolini1, A Scorzai, V Loguercio

  • 1UOC di Medicina Interna, Ospedale S Andrea, II Facoltà di Medicina e Chirurgia, Università di Roma Sapienza, Roma, Italia. massimo.trappolini@uniroma1.it

La Clinica Terapeutica
|January 27, 2009
PubMed

Insights

Splenic infarction can occur after stopping anticoagulant therapy in patients with atrial fibrillation. Prompt re-initiation of anticoagulation led to rapid clinical improvement in this case.

Area of Science:

  • Cardiology
  • Radiology
  • Internal Medicine

Background:

  • Splenic infarction is a rare condition often associated with embolic events.
  • Atrial fibrillation is a common arrhythmia and a significant risk factor for systemic embolism.
  • Dilated cardiomyopathy and mechanical prosthetic valves increase the risk of thromboembolic complications.

Observation:

  • A patient with dilated cardiomyopathy and a mechanical prosthetic valve presented with sudden abdominal pain and fever after discontinuing anticoagulant therapy for atrial fibrillation.
  • Diagnostic imaging, including enhanced-contrast computed tomography, confirmed splenic infarction.
  • Ultrasound and radiography were insufficient for diagnosis.

Findings:

  • Splenic infarction was diagnosed in a patient with atrial fibrillation and a mechanical prosthetic valve.
  • Discontinuation of anticoagulant therapy was a potential trigger for the splenic infarction.
  • Re-initiation of anticoagulant therapy resulted in rapid clinical improvement.

Implications:

  • Splenic infarction should be considered in patients presenting with left hypochondrium pain, particularly those with risk factors like atrial fibrillation or prosthetic valves.
  • Anticoagulant therapy remains the gold standard for treating embolic splenic infarction.
  • Early diagnosis and treatment are crucial for favorable patient outcomes.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...